SynthesisJAMA network open2025

Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.

Fredrik Hieronymus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.